3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Neuroblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
fludarabine phosphate
7
Cyclophosphamide
7
Whole-Body Irradiation
6
Busulfan
6
Mycophenolic Acid
5
fludarabine
4
Peripheral Blood Stem Cell Transplantation
4
Melphalan
4
Azacitidine
4
venetoclax
3
Tacrolimus
3
Cyclosporine
3
Biopsy
3
Vorinostat
2
Specimen Handling
2
Rituximab
2
Methotrexate
2
Etoposide
2
Cytarabine
2
Clofarabine
2
Antilymphocyte Serum
2
thymoglobulin
1
pegylated granulocyte colony-stimulating factor
1
merphos
1
ivosidenib
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
Thiotepa
1
TAK-243
1
Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
Antibodies
×
90 days
×
Clear all
No trials found.